Efavirenz
- Product NDC
- 64980-407
- 11-digit product format
- 649800407
- Labeler code
- 64980
- Product ID
- 64980-407_6267ce9b-6ae9-47ae-835c-567963f6477a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc.
- Application
- ANDA078064
- Marketing category
- ANDA
- Marketing start
- 2017-12-15
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-407-09 | 64980040709 | 90 CAPSULE in 1 BOTTLE (64980-407-09) | 90 capsule | 2017-12-15 | 0000-00-00 | No | No | Current |